FDA PMA FDA Class 3 Approved 🇺🇸 United States

Monitor, Skin Resistance/Skin Temperature, For Insulin Reactions

PMA: P810044 · Supplement: S004 · Decision Jun 12, 2003
Classifications
1
FEI Numbers
0
Registration Numbers
0

Basic Information

Device Name
Monitor, Skin Resistance/Skin Temperature, For Insulin Reactions
Trade Name
SLEEP SENTRY
PMA Number
P810044
Supplement Number
S004
Device Class
FDA Class 3
Product Code
LMY
Generic Name
Monitor, skin resistance/skin temperature, for insulin reactions
Medical Specialty
Unknown
Advisory Committee
General Hospital
Decision
Approved
Decision Code
APPR
Decision Date
June 12, 2003
Date Received
April 30, 2002
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR CHANGES TO THE PHYSICAL DESIGN AND LAYOUT OF THE DEVICE, DEVICE LABELING, AND MANUFACTURING FACILITIES AND PROCESSES. THE MANUFACTURING SITES ARE LOCATED AT DIABETES SENTRY PRODUCTS, INC. (DSP), BELLINGHAM WASHINGTON AND DATREND SYSTEMS, INC., RICHMOND, BC CANADA.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LMY Monitor, Skin Resistance/Skin Temperature, For Insulin Reactions